NCT04161144View on ClinicalTrials.gov

Enhancing Self Regulation Among Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Smoking CessationSmoking, CigaretteNicotine Dependence
Interventions
DRUG

sirolimus

Rapamycin (sirolimus) is administered in three 5mg oral capsules. This administration happens once during the first visit.

DRUG

Placebo

Placebo is administered in three 5mg oral capsules. This administration happens once during the first visit.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT04161144 - Enhancing Self Regulation Among Smokers | Biotech Hunter | Biotech Hunter